company background image
NEOG logo

Neogen NasdaqGS:NEOG Stock Report

Last Price

US$11.56

Market Cap

US$2.5b

7D

-8.5%

1Y

-31.2%

Updated

20 Jan, 2025

Data

Company Financials +

NEOG Stock Overview

Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. More details

NEOG fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for NEOG from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Neogen Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Neogen
Historical stock prices
Current Share PriceUS$11.56
52 Week HighUS$18.58
52 Week LowUS$10.72
Beta1.23
1 Month Change-3.99%
3 Month Change-17.37%
1 Year Change-31.19%
3 Year Change-68.44%
5 Year Change-65.89%
Change since IPO4,423.40%

Recent News & Updates

Neogen: Food Safety Play Is Far From A Safe Pay

Jan 14

Recent updates

Neogen: Food Safety Play Is Far From A Safe Pay

Jan 14

Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Dec 03
Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?

Nov 07
Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?

Neogen Stock: Expect Volatility To Continue Amid Weak Growth

Oct 11

Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Aug 28
Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt

Jul 31
We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt

Neogen Corporation: Challenges Remain

Jun 26

There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

May 21
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Apr 15

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Mar 29
Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Mar 26

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12
Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Jan 09
Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Dec 06
Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Jul 12
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Jun 20
Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Mar 25
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Oct 10

Neogen GAAP EPS of $0.05, revenue of $132.35M

Sep 27

Neogen drops 9% as merger with 3M’s food safety business closes

Sep 01

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Aug 21
Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Neogen: Cut In Half, Still Some Questions

Aug 12

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Aug 04
There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Aug 01

Shareholder Returns

NEOGUS Medical EquipmentUS Market
7D-8.5%3.7%3.2%
1Y-31.2%12.4%24.2%

Return vs Industry: NEOG underperformed the US Medical Equipment industry which returned 12.4% over the past year.

Return vs Market: NEOG underperformed the US Market which returned 24.2% over the past year.

Price Volatility

Is NEOG's price volatile compared to industry and market?
NEOG volatility
NEOG Average Weekly Movement6.4%
Medical Equipment Industry Average Movement8.7%
Market Average Movement6.5%
10% most volatile stocks in US Market18.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: NEOG has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: NEOG's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19812,917John Adentwww.neogen.com

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.

Neogen Corporation Fundamentals Summary

How do Neogen's earnings and revenue compare to its market cap?
NEOG fundamental statistics
Market capUS$2.51b
Earnings (TTM)-US$476.33m
Revenue (TTM)US$913.83m

2.7x

P/S Ratio

-5.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NEOG income statement (TTM)
RevenueUS$913.83m
Cost of RevenueUS$465.21m
Gross ProfitUS$448.62m
Other ExpensesUS$924.95m
Earnings-US$476.33m

Last Reported Earnings

Nov 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.20
Gross Margin49.09%
Net Profit Margin-52.12%
Debt/Equity Ratio33.4%

How did NEOG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 09:03
End of Day Share Price 2025/01/17 00:00
Earnings2024/11/30
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neogen Corporation is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David WestenbergCL King & Associates, Inc.
Steven CrowleyCraig-Hallum Capital Group LLC
Paul KnightCredit Agricole Securities (USA) Inc.